Cargando…
A Review of Intervention Strategies for Areca Nut Use Cessation
BACKGROUND: Areca nut (AN) is one of the world’s most widely used drugs, especially in Asia-Pacific, causing dependence and multiple adverse health impacts. The International Agency for Research on Cancer (IARC) has classified it as a type-1 carcinogen. Despite evidence of harms, its use is cultural...
Autores principales: | Dhingra, Kriti, Jhanjee, Sonali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011838/ https://www.ncbi.nlm.nih.gov/pubmed/36925490 http://dx.doi.org/10.1177/02537176221144711 |
Ejemplares similares
-
A review of the systemic adverse effects of areca nut or betel nut
por: Garg, Apurva, et al.
Publicado: (2014) -
Areca Nut Chewing: Initiation, Addiction, and Harmful Effects Emphasizing the Barriers and Importance of Cessation
por: Athukorala, I. A., et al.
Publicado: (2021) -
The Betel Nut Intervention Trial (BENIT)—A Randomized Clinical Trial for Areca Nut and Betel Quid Cessation: Primary Outcomes
por: Herzog, Thaddeus A., et al.
Publicado: (2023) -
Evaluation of Successfulness of Capacity Building Programmes on Smokeless Tobacco and Areca Nut Cessation
por: Jayasinghe, Ruwan Duminda, et al.
Publicado: (2021) -
Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT)
por: Paulino, Yvette C., et al.
Publicado: (2020)